title: Effect of cholinergic agonists and antagonists on gallbladder volume in fasting man.
abstract: The effect of direct cholinergic stimulation and blockade on gallbladder volume, determined by real-time ultrasonography (RUS), was evaluated in twenty normal, fasting subjects. Eleven subjects received atropine sulphate or placebo and 9 subjects a series of 3 injection of prostigmine, bethanechol or placebo, randomly assigned, at intervals of 24 h. RUS was performed under basal conditions after fasting for 12 h and every 5 min after drug injection up to 45 min in the atropine study and up to 60 min after prostigmine and bethanechol. There was no significant variation from fasting gallbladder volume after placebo in either group. After atropine sulphate gallbladder volume at first decreased and then significantly increased. With bethanechol and prostigmine, the volume fell significantly to a trough after 30 to 35 min, and then it returned to the basal value within 60 min. It is suggested that cholinergic mediation is involved in maintaining fasting tone in the gallbladder and that cholinergic stimulation causes contraction of the gallbladder by a direct effect.
authors.affiliation: Istituto di Fisiopatologia Medica, Università di Chieti, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Marzio
authors.forename: F
authors.initials: F
authors.lastname: Capone
authors.forename: M
authors.initials: M
authors.lastname: Neri
authors.forename: F
authors.initials: F
authors.lastname: di Felice
authors.forename: V
authors.initials: V
authors.lastname: Celiberti
authors.forename: A
authors.initials: A
authors.lastname: Mezzetti
authors.forename: D
authors.initials: D
authors.lastname: Giorgi
authors.forename: F
authors.initials: F
authors.lastname: Cuccurullo
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D005215:Fasting; D005260:Female; D005704:Gallbladder / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D014463:Ultrasonography
chemical_list: D010276:Parasympatholytics; D010277:Parasympathomimetics